Sun Pharma announced that the USFDA has granted a tentative approval for an Abbreviated New Drug Application (ANDA) for generic Strattera?, atomoxetine hydrochloride capsules. These atomoxetine ...
HYDERABAD, India & Princeton, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
May 11, 2005 — The U.S. Food and Drug Administration (FDA) approved in February revisions to safety labeling to advise that use of atomoxetine HCl may be linked rarely to severe liver injury, and that ...
In a BSE filing, Aurobindo Pharma said it “has received final approval from the US Food & Drug Administration (USFDA) to manufacture Atomoxetine capsules, 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and ...
Apotex, Teva, Aurobindo Pharma, and Glenmark are among the first companies to gain approval to market Atomoxetine Capsules in various strengths. The Food and Drug Administration (FDA) has approved the ...
New Delhi: Dr Reddy's Laboratories Wednesday announced the launch of Atomoxetine capsules used to treat attention-deficit hyperactivity disorder (ADHD) in the US market. The Hyderabad-based company ...
MORRISTOWN, N.J., Sept 01, 2010 /PRNewswire via COMTEX/ -- Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention ...
PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (NYSE AMEX: LCI) today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application ...
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera , atomoxetine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results